When OpenAI Chief Financial Officer Sarah Friar told colleagues the company was not ready for a 2026 IPO, she was not just flagging a scheduling concern. She was describing a structural problem that no amount of capital can immediately solve.
Documents reviewed by the Wall Street Journal show OpenAI projecting compute spending of $30 billion in 2026, rising to $121 billion in 2028 and $125 billion in 2029. The 2028 spend alone generates projected losses of $85 billion. OpenAI does not expect to break even until 2030, according to the filings. For context: that is roughly the entire annual defense budget of the United States, spent on a single company's AI training infrastructure — before that company generates a single dollar of profit.
By the same projections, Anthropic, its closest competitor, targets $18 billion in revenue this year, $55 billion in 2027, and $148 billion in 2029, the Journal reported. Anthropic projects it will break even in 2028 — two years before OpenAI, and on far lower cumulative losses. The inference cost problem afflicts both companies equally: both told investors that inference expenses — the cost of running models for users — consume more than half of revenue. Scaling revenue faster than inference costs is the central operational challenge neither company has solved.
Friar has made that case internally. She has also been shut out of the conversations where it matters most.
Since August 2025, Friar has not attended key financial meetings at OpenAI, including one with a major investor discussing server procurement, according to The Information. She no longer reports directly to CEO Sam Altman. She reports to Fidji Simo, OpenAI's head of applications and AGI deployment. The reporting line shift has been in place since August 2025, breaking the standard corporate chain where a CFO preparing a company for public markets answers directly to the CEO.
Last week, Simo announced she was taking medical leave. The cause is a worsening neuroimmune condition called POTS, which she disclosed in a memo to staff. She will be absent for several weeks, she said. Greg Brockman will oversee product in her place. Chief Operating Officer Brad Lightcap shifts to a new role focused on special projects. Chief Marketing Officer Kate Rouch is departing to focus on cancer recovery.
Three senior roles in flux. A CFO who does not report to the CEO. And an IPO target that may be six to twelve months away.
OpenAI has retained Goldman Sachs and Morgan Stanley for preliminary public offering discussions, The Information reported, and has held early conversations with law firms Cooley and Wachtell Lipton Rosen & Katz. Altman has told people he wants OpenAI to list before Anthropic, which is also targeting a public debut. The competitive framing is consistent with Altman's history. But public markets do not award style points for speed.
Public markets demand audited financials, quarterly earnings calls, and institutional investors asking pointed questions about $14 billion losses projected for 2026 alone, Friar's IPO warning, $200 billion in cumulative cash burn before break-even, and a capital structure in which Amazon and NVIDIA — both investors in the recent $122 billion round — are also OpenAI's largest suppliers of the chips and cloud capacity it runs on. When your investors are your vendors, the line between funding and procurement becomes a disclosure problem.
Friar understands those disclosure requirements. The question is whether she is in the room when the decisions that will define them are made.
Joint statements issued after disagreements surface are not governance. The fact that Friar and Altman felt the need to issue one suggests the alignment gap had already become visible.
What to watch: whether Friar's influence grows as Simo recovers, or whether the current structure — CFO through the head of applications, not directly to the CEO — remains the operating reality as OpenAI moves toward a filing. The financial numbers are not the blocker. The governance is.